Statistics in drug advertising: What they reveal is suggestive what they hide is vital

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1015-1018

  Lexchin, J ^a,b,c  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENCE INTERVAL; CONSUMER; DRUG INDUSTRY; DRUG MARKETING; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; STATISTICAL SIGNIFICANCE;

CONFOUNDING FACTORS (EPIDEMIOLOGY);

EID: 77953867049     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02398.x     Document Type: Review

References (25)

1. Twain M. Chapters From My Autobiography, 2006. http://www.gutenberg.org/ files/19987/19987.txt (accessed January 2010).
2. Othman N, Vitry A, Roughead EE. Quality of pharmaceutical advertisements in medical journals: a systematic review. PLoS ONE 2009 4 : e6350.
3. Frosch DL, Grande D, Tam DM, Kravitz RL. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 2010 100 : 24 32.
4. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 1992 116 : 912 919.
5. Lexchin J, Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ 1994 151 : 47 54.
6. Haynes RB. Purpose and procedure. Ann Intern Med 1991 114 (Suppl. 1 A6 7.
7. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996 124 : 485 489.
8. Rochon PA, Gurwitz JH, Cheung M et al. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 1994 272 : 108 113.
9. Mindell J, Kemp T. Only two fifiths of advertisements cited published, peer reviewed references. BMJ 1997 315 : 1622.
10. Montgomery BD, Mansfield PR, Spurling GK, Ward AM. Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study BMC Public Health 2008 8 : 167.
11. Gutknecht DR. Evidence-based advertising? A survey of four major journals J Am Board Fam Pract 2001 14 : 197 200.
12. Lankinen KS, Levola T, Marttinen K et al. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf 2004 13 : 789 795.
13. Cooper RJ, Schriger DL, Wallace RC et al. The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med 2003 18 : 294 297.
14. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine.
15. Bobbio M, Demichelis B, Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet 1994 343 : 1209 1211.
16. Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med 1992 92 : 121 124.
17. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 1992 117 : 916 921.
18. Cranney M, Walley T. Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract 1996 46 : 661 663.
19. Lexchin J. How patient outcomes are reported in drug advertisements: review of Canadian medical journals. Can Fam Physician 1999 45 : 1213 1216.
20. Pharmaceutical Advertising Advisory Board. Code of Advertising Acceptance.
21. Loke TW, Koh FC, Ward JE. Pharmaceutical advertisement claims in Australian medical publications: is evidence accessible, compelling and communicated comprehensively? Med J Aust 2002 177 : 291 293.
22. Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract 2000 49 : 1092 1098.
23. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs what are Americans being sold? Lancet 2001 358 : 1141 1146.
24. Kaphingst IA, Dejong W, Rudd RE, Daltroy LH. A content analysis of direct-to-consumer television prescription drug advertising. J Health Commun 2004 9 : 515 528.
25. Frosch DL, Krueger PM, Hornik RC et al. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med 2007 5 : 6 13.